Today’s growing pipeline of biologics is driving an increasing demand for technically advanced manufacturing support, in which contract development and manufacturing organizations (CDMOs) are playing a vital role. With biologics representing most top-selling drugs and the fastest-growing pharmaceutical segment, there is a growing strategic role for CDMOs that specialize in sterile manufacturing for injectable medications. This eBook offers insights into the parenteral and fill-finish manufacturing markets, opportunities, and recent investments in the space.  Download now to learn more.